Sinovac Biotech, Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
Week In Review: Sinovac's Privatization Offer Draws $459 Million Outside Bid
Article By: ChinaBio® Today
Saturday, July 1, 2017 7:14 PM EDT
Shandong Sinobioway Biomedicine topped management's $402 million bid to privatize China vaccine maker Sinovac with a $459 million offer of its own. Sinovac is a Beijing vaccine company with legacy vaccines for hepatitis A and B.
In this article: AZN, GE, SVA, HCM
Read
Week In Review: Beijing's Berry Genomics Valued At $619 Million In Reverse Merger
Article By: ChinaBio® Today
Saturday, December 24, 2016 4:36 PM EDT
Berry Genomics, a Beijing genetic testing company, will IPO via a reverse merger with Chengdu Tianxing Instrument & Meter (SHZ: 0710) at a valuation of $619 million on China's Shenzhen market.
In this article: SVA, BGNE
Read
Week In Review: New Deals Fund China Life Science Innovation
Article By: ChinaBio® Today
Saturday, September 3, 2016 1:30 PM EDT
Beijing Allcure Medical Technology, a radiology oncology startup developing big data/cloud computing applications, raised $27 million in an A+ funding round.
In this article: CCM, SVA
Read
Week In Review: HighLight Capital Raising $229 Million For China Healthcare
Article By: ChinaBio® Today
Saturday, May 28, 2016 12:30 PM EDT
HighLight Capital of Shanghai, a healthcare early-stage private equity investor, is close to completing fundraising for its $229 million second fund, according to media reports.
In this article: SVA
Read
Week In Review: Deals Dominate China Biopharma News
Article By: ChinaBio® Today
Saturday, April 2, 2016 1:53 PM EDT
AliHealth, a subsidiary of China e-commerce giant Alibaba, will invest $35 million to acquire a 25% stake in China Resources Wandong Medical Equipment's medical imaging unit.
In this article: AIQ, GSK, TMO, AFFY, SVA, BABA
Read

PARTNER HEADLINES

Latest Tweets for $SVA

No tweets yet!